ConductScience.org, home

Trial · NCT05530252

Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis

NCT05530252, Phase 4, Completed, Beijing Stomatological Hospital, Capital Medical University; results first posted 2024-04-30

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis. Trials, record NCT05530252. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05530252

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis
NCT number
NCT05530252
Status
Completed
Phases
Phase 4
Enrollment
51 participants, actual
Lead sponsor
Beijing Stomatological Hospital, Capital Medical University
Conditions
Periodontitis
Interventions
Oral biological antimicrobial gel, minocycline hydrochloride ointment, SRP
First posted
2022-09-07
Last updated
2024-04-30
Results first posted
2024-04-30

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPeriodontal Probing DepthChange from Baseline Periodontal probing depth at 90 daysfrom the gingival margin to the bottom of the periodontal pocket were assessed using a Williams periodontal probe((Hu-Friedy)
PrimaryAttachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)Change from Baseline Attachment level at 90 daysfrom the cementoenamel junction, crown margin or restoration to the bottom of the pocket
PrimaryBleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.Change from Bleeding index at 90 days
Bleeding index : 0 = normal appearance of the gingiva and no bleeding on sulcus probing. 1. = normal appearance of the gingiva but bleeding on probing of the sulcus. 2. = bleeding on probing and gingival color change without swelling. 3. = bleeding on probing, gingival color change with mild swelling. 4. = bleeding on probing with marked gingival swelling, with or without color change. 5. = bleeding on probing, L Spontaneous bleeding, gingival color change with marked swelling, with or without ulceration.

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPeriodontal Probing DepthChange from Baseline Periodontal probing depth at 90 daysThree subjects did not return to the clinic as required and were not included in the final data analysis of the studymillimeterMEAN
PRIMARYAttachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)Change from Baseline Attachment level at 90 daysThree subjects did not return to the clinic as required and were not included in the final data analysis of the studymillimeterMEAN
PRIMARYBleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.Change from Bleeding index at 90 daysThree subjects did not return to the clinic as required and were not included in the final data analysis of the studyscore on a scaleMEAN

Results by group9

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Periodontal Probing DepthAMP Group2.5Inter-Quartile Range 2.4 to 2.6millimeter
Periodontal Probing DepthPerio Group3.2Inter-Quartile Range 3.1 to 3.3millimeter
Periodontal Probing DepthSRP Group3.4Inter-Quartile Range 3.3 to 3.4millimeter
Attachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)AMP Group1.0Inter-Quartile Range 0.9 to 1millimeter
Attachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)Perio Group1.7Inter-Quartile Range 1.5 to 1.9millimeter
Attachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)SRP Group2.0Inter-Quartile Range 1.7 to 2.2millimeter
Bleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.AMP Group0.7Inter-Quartile Range 0.6 to 0.9score on a scale
Bleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.Perio Group1.1Inter-Quartile Range 1.0 to 1.3score on a scale
Bleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.SRP Group1.3Inter-Quartile Range 1.2 to 1.4score on a scale

Participant flow9

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAMP Group17
Overall StudySTARTEDPerio Group17
Overall StudySTARTEDSRP Group17
Overall StudyCOMPLETEDAMP Group16
Overall StudyCOMPLETEDPerio Group16
Overall StudyCOMPLETEDSRP Group16
Overall StudyNOT COMPLETEDAMP Group1
Overall StudyNOT COMPLETEDPerio Group1
Overall StudyNOT COMPLETEDSRP Group1

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals9

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityAMP Group017
Total, all-cause mortalityPerio Group017
Total, all-cause mortalitySRP Group017
Total, other adverse eventsAMP Group017
Total, other adverse eventsPerio Group017
Total, other adverse eventsSRP Group017
Total, serious adverse eventsAMP Group017
Total, serious adverse eventsPerio Group017
Total, serious adverse eventsSRP Group017

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05530252

GET https://conductscience.org/api/trials/v1/NCT05530252/registered